|
PRKAG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04560002270426E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67235999999349E-05 |
| Normal-vs-Stage2 |
3.963200E-01 |
| Normal-vs-Stage3 |
1.62647673107585E-12 |
| Normal-vs-Stage4 |
1.67370006742829E-10 |
| Stage1-vs-Stage2 |
3.453000E-01 |
| Stage1-vs-Stage3 |
1.053550E-02 |
| Stage1-vs-Stage4 |
9.049700E-02 |
| Stage2-vs-Stage3 |
6.169900E-02 |
| Stage2-vs-Stage4 |
1.009980E-01 |
| Stage3-vs-Stage4 |
5.200800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30710006654533E-10 |
| Normal-vs-AfricanAmerican |
6.365600E-02 |
| Normal-vs-Asian |
6.005800E-01 |
| Caucasian-vs-AfricanAmerican |
6.678400E-01 |
| Caucasian-vs-Asian |
3.370800E-01 |
| AfricanAmerican-vs-Asian |
3.858600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06779999953233E-07 |
| Normal-vs-Female |
1.20599999986482E-07 |
| Male-vs-Female |
4.629600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.111800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.61660000000496E-06 |
| Normal-vs-Age(61-80Yrs) |
2.09929995609315E-09 |
| Normal-vs-Age(81-100Yrs) |
4.47469999942385E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.402200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.117800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.300000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.845000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.002100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.194590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.25090000000039E-05 |
| Normal-vs-Grade 2 |
3.28530000004434E-06 |
| Normal-vs-Grade 3 |
3.83640008649877E-10 |
| Normal-vs-Grade 4 |
1.66067160023431E-12 |
| Grade 1-vs-Grade 2 |
8.420200E-02 |
| Grade 1-vs-Grade 3 |
3.731800E-01 |
| Grade 1-vs-Grade 4 |
8.160600E-01 |
| Grade 2-vs-Grade 3 |
2.525600E-01 |
| Grade 2-vs-Grade 4 |
1.083720E-02 |
| Grade 3-vs-Grade 4 |
1.141420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.6574519534629E-12 |
| Normal-vs-ccB subtype |
1.914560E-01 |
| ccA subtype-vs-ccB subtype |
4.124300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.632100E-04 |
| Normal-vs-N1 |
3.34450023231625E-10 |
| N0-vs-N1 |
5.219100E-03 |
|
|
